Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
TNFRSF6B belongs to the tumor necrosis factor receptor superfamily. Zusätzlich bieten wir Ihnen TNFRSF6B Proteine (10) und TNFRSF6B Kits (9) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 81 products:
Human Monoclonal TNFRSF6B Primary Antibody für IHC (p), ELISA - ABIN563778
Wu, Huang, Hsieh, Hsiao, Lee, Lin: EGFR-driven up-regulation of decoy receptor 3 in keratinocytes contributes to the pathogenesis of psoriasis. in Biochimica et biophysica acta 2013
The combination of decoy receptor 3, soluble urokinase type plasminogen activator receptor (zeige PLAUR Antikörper), and procalcitonin improved the sensitivity and specificity of diagnosis of sepsis, suggesting that use of the combination of three indexes enhanced the efficiency of sepsis diagnosis.
Compared with the control, miR (zeige MLXIP Antikörper)-340 was significantly lower in the serum of hepatocellular carcinoma patients (p<0.01). miR (zeige MLXIP Antikörper)-340 was lower in HCC (zeige FAM126A Antikörper) tissues than in adjacent; however, DcR3, TGF-beta1 (zeige TGFB1 Antikörper) and Smad2 (zeige SMAD2 Antikörper) were higher.
DcR3 treatment caused HepG2 cell cytoskeleton remodeling, inhibited E-cadherin (zeige CDH1 Antikörper) expression, and promoted cell migration.
DcR3 gene polymorphisms are associated with sporadic breast infiltrating ductal carcinoma risk in Northeast Chinese females
Study found that both transcriptional expression and post-transcriptional DcR3 expression DcR3 expression were significantly up-regulated in colorectal cancer (CRC (zeige CALR Antikörper)) tissues. DcR3 was found to be playing a critical role in CRC (zeige CALR Antikörper) proliferation and migration in vitro and in tumorigenesis and metastasis in vivo.
Higher plasma DcR3 level was related to better coronary collateral circulation (CCC) formation and displayed potent predictive power for CCC status in patients with coronary artery disease.
High serum DcR3 levels are associated with disease severity in nonatopic asthma patients.
Results show that DcR3 engages TNF (zeige TNF Antikörper) ligands: FasL (zeige FASL Antikörper), LIGHT, and TL1A (zeige TNFSF15 Antikörper) in a structurally similar fashion and its promiscuity is due to recognition of backbone atoms and invariant side chains.
These results raise the possibility for involvement of TL1A (zeige TNFSF15 Antikörper)/DR3/DR3 (zeige TNFRSF25 Antikörper)-mediated mechanisms in epithelial-mesenchymal interactions and the development of inflammation-induced intestinal fibrosis in Crohn's disease.
when idiopathic pulmonary fibrosis cells interact with collagen matrix, aberrantly activated Akt (zeige AKT1 Antikörper) increases DcR3 expression via GSK-3beta-NFATc1 (zeige NFATC1 Antikörper) and protects IPF cells from the FasL (zeige FASL Antikörper)-dependent apoptotic pathway.
This gene belongs to the tumor necrosis factor receptor superfamily. The encoded protein is postulated to play a regulatory role in suppressing FasL- and LIGHT-mediated cell death. It acts as a decoy receptor that competes with death receptors for ligand binding. Over-expression of this gene has been noted in gastrointestinal tract tumors. Read-through transcription into this gene from the neighboring upstream gene, which encodes regulator of telomere elongation helicase 1 (RTEL1), generates a non-coding transcript.
decoy receptor 3
, decoy receptor for Fas ligand
, tumor necrosis factor receptor superfamily member 6B
, tumor necrosis factor receptor superfamily, member 6b
, tumor necrosis factor receptor superfamily, member 6b, decoy